Literature DB >> 16749791

Synthesis of 3-hydroxy-6-oxo[1,2,4]triazin-1-yl alaninamides, a new class of cyclic dipeptidyl ureas.

María Sañudo1, Stefano Marcaccini, Sara Basurto, Tomás Torroba.   

Abstract

Cyclohexyl or benzyl isocyanide, benzoyl-, or 4-methoxybenzoylformic acid and semicarbazones underwent Ugi reactions in methanol for 3 days to give the Ugi adducts, which were then stirred with sodium ethoxide in ethanol for 12 h to give 3-hydroxy-6-oxo[1,2,4]triazin-1-yl alaninamides. The X-ray diffraction structure of the first example showed the tautomer having the proton in the O2 atom that was fixed in the crystal by packing in dimers with a H-bond distance of 1.9 A. Selected [1,2,4]triazines were treated with diazomethane for 12 h to get the O-methyl derivatives. Both hydroxy and O-methyl derivatives obtained by this method constitute a new class of pseudopeptidic [1,2,4]triazines composed of two different amino acids, arylglycine and alanine derivatives, in which the N-terminal arylglycine and the peptidic amide nitrogen atoms are bonded through a urea moiety.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16749791     DOI: 10.1021/jo060434y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Ugi post-condensation copper-triggered oxidative cascade towards pyrazoles.

Authors:  Aurélie Dos Santos; Laurent El Kaim; Laurence Grimaud; Caroline Ronsseray
Journal:  Beilstein J Org Chem       Date:  2011-09-21       Impact factor: 2.883

Review 2.  Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.

Authors:  Gijs Koopmanschap; Eelco Ruijter; Romano Va Orru
Journal:  Beilstein J Org Chem       Date:  2014-03-04       Impact factor: 2.883

3.  Optimization of the Ugi reaction using parallel synthesis and automated liquid handling.

Authors:  Jean-Claude Bradley; Khalid Baig Mirza; Tom Osborne; Antony Wiliams; Kevin Owens
Journal:  J Vis Exp       Date:  2008-11-11       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.